UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Clinical Guideline on Paget’s Disease of bone—A Guideline or a Review?

Journal of bone and mineral research, 2019-04, Vol.34 (4), p.577-578

Langdahl, BL

2019

Volltextzugriff (PDF)

Is There a Place for Bone Turnover Markers in the Management of Osteoporosis?

Journal of bone and mineral research, 2018-07, Vol.33 (7), p.1197-1198

Langdahl, BL

2018

Volltextzugriff (PDF)

A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.E729-E733

2014

Volltextzugriff (PDF)

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

Osteoporosis international, 2009-12, Vol.20 (12), p.2095-2104

2009

Volltextzugriff (PDF)

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

Osteoporosis international, 2012-09, Vol.23 (9), p.2257-2276

2012

Volltextzugriff (PDF)

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

Osteoporosis international, 2011-10, Vol.22 (10), p.2709-2719

2011

Volltextzugriff (PDF)

Temporomandibular disorders and psychosocial status in osteogenesis imperfecta - a cross-sectional study

BMC oral health, 2018-03, Vol.18 (1), p.35-35, Article 35

2018

Volltextzugriff (PDF)

Diagnosis and management of primary hyperparathyroidism in Europe

QJM : An International Journal of Medicine, 2012-06, Vol.105 (6), p.519-525

2012

Volltextzugriff (PDF)

The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Osteoporosis international, 2021, Vol.32 (1), p.185-191

2021

Volltextzugriff (PDF)

Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)

Current medical research and opinion, 2014-08, Vol.30 (8), p.1607-1616

2014

Volltextzugriff (PDF)

A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

Osteoporosis international, 2023-11, Vol.34 (11), p.1893-1906

2023

Volltextzugriff (PDF)

Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomography

Scandinavian journal of rheumatology, 2018-03, Vol.47 (2), p.110-116

2018

Volltextzugriff (PDF)

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

Osteoporosis international, 2020-11, Vol.31 (11), p.2231-2241

2020

Volltextzugriff (PDF)

Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis

Osteoporosis international, 2011-10, Vol.22 (10), p.2655-2666

2011

Volltextzugriff (PDF)

Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies

Osteoporosis international, 2020, Vol.31 (1), p.31-42

2020

Volltextzugriff (PDF)

Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study

Osteoporosis international, 2021, Vol.32 (1), p.63-73

2021

Volltextzugriff (PDF)

Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk

Osteoporosis international, 2011-04, Vol.22 (4), p.1145-1156

2011

Volltextzugriff (PDF)

Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis

Osteoporosis international, 2021, Vol.32 (1), p.173-184

2021

Volltextzugriff (PDF)

Polymorphisms in the ALOX12 gene and osteoporosis

Osteoporosis international, 2011-08, Vol.22 (8), p.2249-2259

2011

Volltextzugriff (PDF)

A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women

Bone (New York, N.Y.), 1997-03, Vol.20 (3), p.289-294

1997

Volltextzugriff (PDF)

Comparison of bone turnover markers in peripheral blood and bone marrow aspirate

Bone (New York, N.Y.), 2018-11, Vol.116, p.315-320

2018

Volltextzugriff (PDF)

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective

Osteoporosis international, 2015-02, Vol.26 (2), p.513-519

2015

Volltextzugriff (PDF)

A TA Repeat Polymorphism in the Estrogen Receptor Gene Is Associated with Osteoporotic Fractures but Polymorphisms in the First Exon and Intron Are Not

Journal of bone and mineral research, 2000-11, Vol.15 (11), p.2222-2230

2000

Volltextzugriff (PDF)

Effectiveness and characteristics of multifaceted osteoporosis group education—a systematic review

Osteoporosis international, 2014-04, Vol.25 (4), p.1209-1224

2014

Volltextzugriff (PDF)

Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series

Osteoporosis international, 2019-02, Vol.30 (2), p.513-517

2019

Volltextzugriff (PDF)

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Clinical Guideline on Paget’s Disease of bone—A Guideline or a Review?

Is There a Place for Bone Turnover Markers in the Management of Osteoporosis?

A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

Temporomandibular disorders and psychosocial status in osteogenesis imperfecta - a cross-sectional study

Diagnosis and management of primary hyperparathyroidism in Europe

The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)

A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomography

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis

Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies

Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study

Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk

Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis

Polymorphisms in the ALOX12 gene and osteoporosis

A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women

Comparison of bone turnover markers in peripheral blood and bone marrow aspirate

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective

A TA Repeat Polymorphism in the Estrogen Receptor Gene Is Associated with Osteoporotic Fractures but Polymorphisms in the First Exon and Intron Are Not

Effectiveness and characteristics of multifaceted osteoporosis group education—a systematic review

Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series

Suchergebnisse filtern